265 related articles for article (PubMed ID: 30923703)
1. Long Noncoding RNAs: Emerging Players in Medulloblastoma.
Laneve P; Rea J; Caffarelli E
Front Pediatr; 2019; 7():67. PubMed ID: 30923703
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic Drivers in Pediatric Medulloblastoma.
Roussel MF; Stripay JL
Cerebellum; 2018 Feb; 17(1):28-36. PubMed ID: 29178021
[TBL] [Abstract][Full Text] [Related]
3. Identification and Functional Characterization of Novel MYC-Regulated Long Noncoding RNAs in Group 3 Medulloblastoma.
Rea J; Carissimo A; Trisciuoglio D; Illi B; Picard D; Remke M; Laneve P; Caffarelli E
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359754
[TBL] [Abstract][Full Text] [Related]
4. Decoding Somatic Driver Gene Mutations and Affected Signaling Pathways in Human Medulloblastoma Subgroups.
Robbins CJ; Bou-Dargham MJ; Sanchez K; Rosen MC; Sang QA
J Cancer; 2018; 9(24):4596-4610. PubMed ID: 30588243
[TBL] [Abstract][Full Text] [Related]
5. The Non-coding Side of Medulloblastoma.
Laneve P; Caffarelli E
Front Cell Dev Biol; 2020; 8():275. PubMed ID: 32528946
[TBL] [Abstract][Full Text] [Related]
6. The therapeutic and diagnostic potential of regulatory noncoding RNAs in medulloblastoma.
Joshi P; Katsushima K; Zhou R; Meoded A; Stapleton S; Jallo G; Raabe E; Eberhart CG; Perera RJ
Neurooncol Adv; 2019; 1(1):vdz023. PubMed ID: 31763623
[TBL] [Abstract][Full Text] [Related]
7. The long noncoding RNA linc-NeD125 controls the expression of medulloblastoma driver genes by microRNA sponge activity.
Laneve P; Po A; Favia A; Legnini I; Alfano V; Rea J; Di Carlo V; Bevilacqua V; Miele E; Mastronuzzi A; Carai A; Locatelli F; Bozzoni I; Ferretti E; Caffarelli E
Oncotarget; 2017 May; 8(19):31003-31015. PubMed ID: 28415684
[TBL] [Abstract][Full Text] [Related]
8. The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cells.
Varon M; Levy T; Mazor G; Ben David H; Marciano R; Krelin Y; Prasad M; Elkabets M; Pauck D; Ahmadov U; Picard D; Qin N; Borkhardt A; Reifenberger G; Leprivier G; Remke M; Rotblat B
Int J Cancer; 2019 Dec; 145(12):3402-3413. PubMed ID: 31081944
[TBL] [Abstract][Full Text] [Related]
9. FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma.
Remke M; Hielscher T; Korshunov A; Northcott PA; Bender S; Kool M; Westermann F; Benner A; Cin H; Ryzhova M; Sturm D; Witt H; Haag D; Toedt G; Wittmann A; Schöttler A; von Bueren AO; von Deimling A; Rutkowski S; Scheurlen W; Kulozik AE; Taylor MD; Lichter P; Pfister SM
J Clin Oncol; 2011 Oct; 29(29):3852-61. PubMed ID: 21911727
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
[TBL] [Abstract][Full Text] [Related]
11. Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases.
Wu P; Zuo X; Deng H; Liu X; Liu L; Ji A
Brain Res Bull; 2013 Aug; 97():69-80. PubMed ID: 23756188
[TBL] [Abstract][Full Text] [Related]
12. The decalog of long non-coding RNA involvement in cancer diagnosis and monitoring.
Kunej T; Obsteter J; Pogacar Z; Horvat S; Calin GA
Crit Rev Clin Lab Sci; 2014 Dec; 51(6):344-57. PubMed ID: 25123609
[TBL] [Abstract][Full Text] [Related]
13. Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic Insights.
Khatua S; Song A; Citla Sridhar D; Mack SC
Curr Neuropharmacol; 2018; 16(7):1045-1058. PubMed ID: 29189165
[TBL] [Abstract][Full Text] [Related]
14. Data mining of pediatric medulloblastoma microarray expression reveals a novel potential subdivision of the Group 4 molecular subgroup.
Castillo-Rodríguez RA; Dávila-Borja VM; Juárez-Méndez S
Oncol Lett; 2018 May; 15(5):6241-6250. PubMed ID: 29616106
[TBL] [Abstract][Full Text] [Related]
15. MRI features as a helpful tool to predict the molecular subgroups of medulloblastoma: state of the art.
Colafati GS; Voicu IP; Carducci C; Miele E; Carai A; Di Loreto S; Marrazzo A; Cacchione A; Cecinati V; Tornesello A; Mastronuzzi A
Ther Adv Neurol Disord; 2018; 11():1756286418775375. PubMed ID: 29977341
[TBL] [Abstract][Full Text] [Related]
16. Molecular Subgrouping of Medulloblastoma: Impact Upon Research and Clinical Practice.
Gupta T; Shirsat N; Jalali R
Curr Pediatr Rev; 2015; 11(2):106-19. PubMed ID: 26133181
[TBL] [Abstract][Full Text] [Related]
17. Gene expression analyses of the spatio-temporal relationships of human medulloblastoma subgroups during early human neurogenesis.
Hooper CM; Hawes SM; Kees UR; Gottardo NG; Dallas PB
PLoS One; 2014; 9(11):e112909. PubMed ID: 25412507
[TBL] [Abstract][Full Text] [Related]
18. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma.
Shackleford GM; Shi XH; Swanson KS; Mahdi MY; Gonzalez-Gomez I; Asgharzadeh S; D'Apuzzo M; Erdreich-Epstein A; Moats RA
PLoS One; 2016; 11(6):e0156907. PubMed ID: 27310018
[TBL] [Abstract][Full Text] [Related]
19. Nkx2-2as Suppression Contributes to the Pathogenesis of Sonic Hedgehog Medulloblastoma.
Zhang Y; Wang T; Wang S; Xiong Y; Zhang R; Zhang X; Zhao J; Yang AG; Wang L; Jia L
Cancer Res; 2018 Feb; 78(4):962-973. PubMed ID: 29229597
[TBL] [Abstract][Full Text] [Related]
20. Case-based review: pediatric medulloblastoma.
Kline CN; Packer RJ; Hwang EI; Raleigh DR; Braunstein S; Raffel C; Bandopadhayay P; Solomon DA; Aboian M; Cha S; Mueller S
Neurooncol Pract; 2017 Sep; 4(3):138-150. PubMed ID: 29692919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
